# Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects

> **NCT05175430** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Paroxetine
- **DRUG:** Lysergic Acid Diethylamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05175430
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-24
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-03-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05175430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05175430, "Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT05175430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*